5281W-12 A Phase 2, Proof of Concept, Randomized,Placebo-Controlled, Parallel Group Study to Evaluat

VICTORY AF. A Phase 2,Proof of Concept,Randomized,Placebo-Controlled,Parallel Group Study to Evaluate the Effect of Ranolazine & Dronedarone When Given Alone and in Combination on Atrial Fibrillation Burden in Subjects with Paroxysmal Atrial Fibrillation

Type of Study
Heart & Vascular - Electrophysiology
Short Description

The primary objective of this study is to evaluate the effect of ranolazine and of low dose dronedarone when given alone and in combination at different dose levels on Atrial Fibrillation Burden.

Principal Investigator
Darryl Wells, MD
Eligibility Notes

Males and females aged 18 years and older, who have a history of Paroxysmal Atrial Fibrillation documented within the prior 12 months, but not Persistent or Permanent Atrial Fibrillation.

Contact Name
Inger Rasmussen